B. Asztalos, L. Cupples, S. Demissie, K. Horvath, C. Cox et al., High-Density Lipoprotein Subpopulation Profile and Coronary Heart Disease Prevalence in Male Participants of the Framingham Offspring Study, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.24, issue.11, pp.2181-2188, 2004.
DOI : 10.1161/01.ATV.0000146325.93749.a8

B. Asztalos, K. Horvath, J. Mcnamara, P. Roheim, J. Rubinstein et al., Effects of atorvastatin on the HDL subpopulation profile of coronary heart disease patients, The Journal of Lipid Research, vol.43, issue.10, pp.1701-1708, 2002.
DOI : 10.1194/jlr.M200037-JLR200

B. Asztalos, P. Roheim, R. Milani, M. Lefevre, J. Mcnamara et al., Distribution of ApoA-I-Containing HDL Subpopulations in Patients With Coronary Heart Disease, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.20, issue.12, pp.2670-2676, 2000.
DOI : 10.1161/01.ATV.20.12.2670

B. Asztalos, C. Sloop, L. Wong, and P. Roheim, Two-dimensional electrophoresis of plasma lipoproteins: Recognition of new apo A-I-containing subpopulations, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.1169, issue.3, pp.291-300, 1993.
DOI : 10.1016/0005-2760(93)90253-6

A. Barrans, B. Jaspard, R. Barbaras, H. Chap, B. Perret et al., Pre-?? HDL: structure and metabolism, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.1300, issue.2, pp.73-85, 1996.
DOI : 10.1016/0005-2760(95)00236-7

P. Blanche, E. Gong, T. Forte, and A. Nichols, Characterization of human high-density lipoproteins by gradient gel electrophoresis, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.665, issue.3, pp.408-427, 1981.
DOI : 10.1016/0005-2760(81)90253-8

M. Clay and P. Barter, Formation of new HDL particles from lipid-free apolipoprotein A-I, J Lipid Res, vol.7, pp.1722-1754, 1996.

P. Fielding, M. Kawano, A. Catapano, A. Zoppo, S. Marcovina et al., Unique Epitope of Apolipoprotein A-I Expressed in Pre-.beta.-1 High-Density Lipoprotein and Its Role in the Catalyzed Efflux of Cellular Cholesterol, Biochemistry, vol.33, issue.22, pp.6981-6986, 1994.
DOI : 10.1021/bi00188a030

N. Fournier, O. Francone, and G. Rothblat, Enhanced efflux of cholesterol from ABCA1-expressing macrophages to serum from type IV hypertriglyceridemic subjects, Atherosclerosis, vol.171, issue.2, pp.287-93, 2003.
DOI : 10.1016/j.atherosclerosis.2003.08.011

H. Hassan, H. Blain, S. Boucher, B. Denis, M. Krimbou et al., Structural modification of plasma HDL by phospholipids promotes efficient ABCA1-mediated cholesterol release, The Journal of Lipid Research, vol.46, issue.7, pp.1457-65, 2005.
DOI : 10.1194/jlr.M400477-JLR200

H. Hattori, T. Kujiraoka, T. Egashira, E. Saito, T. Fujioka et al., Association of Coronary Heart Disease with Pre-??-HDL Concentrations in Japanese Men, Clinical Chemistry, vol.50, issue.3, pp.589-95, 2004.
DOI : 10.1373/clinchem.2003.029207

M. Kawano, T. Miida, C. Fielding, and P. Fielding, Quantitation of pre.beta.-HDL-dependent and nonspecific components of the total efflux of cellular cholesterol and phospholipid, Biochemistry, vol.32, issue.19, pp.5025-5033, 1993.
DOI : 10.1021/bi00070a008

J. Kuivenhoven, G. De-grooth, H. Kawamura, A. Klerkx, F. Wilhelm et al., Effectiveness of Inhibition of Cholesteryl Ester Transfer Protein by JTT-705 in Combination With Pravastatin in Type II Dyslipidemia, The American Journal of Cardiology, vol.95, issue.9, pp.1085-1093, 2005.
DOI : 10.1016/j.amjcard.2004.12.064

S. Kunitake, C. Mendel, and L. Hennessy, Interconversion between apolipoprotein A-Icontaining lipoproteins of pre-beta and alpha electrophoretic mobilities, J Lipid Res, vol.33, issue.12, pp.1807-1823, 1992.

J. Lee, L. Lanningham-foster, E. Boudyguina, T. Smith, E. Young et al., Pre?? high density lipoprotein has two metabolic fates in human apolipoprotein A-I transgenic mice, The Journal of Lipid Research, vol.45, issue.4, pp.716-744, 2004.
DOI : 10.1194/jlr.M300422-JLR200

J. Lee and J. Parks, ATP-binding cassette transporter AI and its role in HDL formation, Current Opinion in Lipidology, vol.16, issue.1, pp.19-25, 2005.
DOI : 10.1097/00041433-200502000-00005

H. Liang, K. Rye, and P. Barter, Dissociation of lipid-free apolipoprotein A-I from high density lipoproteins, J Lipid Res, vol.35, pp.1187-99, 1994.

T. Miida, M. Kawano, C. J. Fielding, and P. Fielding, Regulation of the concentration of pre.beta. high-density lipoprotein in normal plasma by cell membranes and lecithin-cholesterol acyltransferase activity, Biochemistry, vol.31, issue.45, pp.11112-11119, 1992.
DOI : 10.1021/bi00160a022

T. Miida, O. Miyazaki, Y. Nakamura, S. Hirayama, O. Hanyu et al., Analytical performance of a sandwich enzyme immunoassay for prebeta1-HDL in stabilized plasma, The Journal of Lipid Research, vol.44, issue.3, pp.645-50, 2003.
DOI : 10.1194/jlr.D200025-JLR200

T. Miida, K. Sakai, K. Ozaki, Y. Nakamura, T. Yamaguchi et al., Bezafibrate Increases Pre??1-HDL at the Expense of HDL2b in Hypertriglyceridemia, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.20, issue.11, pp.2428-2461, 2000.
DOI : 10.1161/01.ATV.20.11.2428

O. Miyazaki, J. Kobayashi, I. Fukamachi, T. Miida, H. Bujo et al., A new sandwich enzyme immunoassay for measurement of plasma pre-ß1-HDL levels, J Lipid Res, vol.41, pp.2083-2091, 2000.

V. Nambi and C. Ballantyne, Fat, Fit, and Leading the Charge: The Evolution of Measuring High-Density Lipoprotein Subpopulations, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.25, issue.10, pp.2013-2018, 2005.
DOI : 10.1161/01.ATV.0000186043.86570.4f

J. Nofer, B. Kehrel, M. Fobker, B. Levkau, G. Assmann et al., HDL and arteriosclerosis: beyond reverse cholesterol transport, Atherosclerosis, vol.161, issue.1, pp.1-16, 2002.
DOI : 10.1016/S0021-9150(01)00651-7

O. Connor, P. M. Zysow, B. R. Schoenhaus, S. Ishida, and B. , Prebeta-1 HDL in plasma of normolipidemic individuals: influences of plasma lipoproteins, age, and gender, J Lipid Res, vol.39, pp.670-678, 1998.

H. Okamoto, F. Yonemori, K. Wakitani, T. Minowa, K. Maeda et al., A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits, Nature, vol.406, issue.6792, pp.203-210, 2000.
DOI : 10.1038/35018119

P. Pussinen, E. Malle, J. Metso, W. Sattler, J. Raynes et al., Acute-phase HDL in phospholipid transfer protein (PLTP)-mediated HDL conversion, Atherosclerosis, vol.155, issue.2, pp.297-305, 2001.
DOI : 10.1016/S0021-9150(00)00568-2

D. Rader, Regulation of reverse cholesterol transport and clinical implications, The American Journal of Cardiology, vol.92, issue.4, pp.42-51, 2003.
DOI : 10.1016/S0002-9149(03)00615-5

M. Ritter and A. Scanus, Role of apolipoprotein A-I in the structure of human serum high density lipoproteins. Reconstitution studies, J Biol Chem, vol.252, issue.4, pp.1208-1224, 1977.

K. Rye and P. Barter, Formation and Metabolism of Prebeta-Migrating, Lipid-Poor Apolipoprotein A-I, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.24, issue.3, pp.421-429, 2004.
DOI : 10.1161/01.ATV.0000104029.74961.f5

E. Skinner, High-density lipoprotein subclasses, Current Opinion in Lipidology, vol.5, issue.3, pp.241-248, 1994.
DOI : 10.1097/00041433-199405030-00013

D. Sviridov and P. Nestel, Dynamics of reverse cholesterol transport: protection against atherosclerosis, Atherosclerosis, vol.161, issue.2, pp.245-54, 2002.
DOI : 10.1016/S0021-9150(01)00677-3

D. Sviridov, L. Pyle, M. Jauhiainen, C. Ehnholm, and N. Fidge, Deletion of the propeptide of apolipoprotein A-I reduces protein expression but stimulates effective conversion of prebetahigh density lipoprotein to alpha-high density lipoprotein, J Lipid Res, vol.41, issue.11, pp.1872-82, 2000.

D. Sviridov, O. Miyazaki, K. Theodore, A. Hoang, I. Fukamachi et al., Delineation of the Role of Pre-beta1-HDL in Cholesterol Efflux Using Isolated Pre-beta1-HDL, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.22, issue.9, p.1482, 2002.
DOI : 10.1161/01.ATV.0000029120.44088.FE

A. Tall, Plasma cholesteryl ester transfer protein and high-density lipoproteins: new insights from molecular genetic studies, Journal of Internal Medicine, vol.34, issue.1, pp.5-12, 1995.
DOI : 10.1111/j.1365-2796.1995.tb01133.x

H. Towbin, T. Staehelin, and J. Gordon, Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications., Proceedings of the National Academy of Sciences, vol.76, issue.9, pp.4350-4354, 1979.
DOI : 10.1073/pnas.76.9.4350

N. Wang and A. Tall, Regulation and Mechanisms of ATP-Binding Cassette Transporter A1-Mediated Cellular Cholesterol Efflux, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.23, issue.7, pp.1178-84, 2003.
DOI : 10.1161/01.ATV.0000075912.83860.26

P. Wilson, R. Abbott, and W. Castelli, High density lipoprotein cholesterol and mortality. The Framingham Heart Study, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.8, issue.6, pp.737-778, 1988.
DOI : 10.1161/01.ATV.8.6.737

R. Sturk and . Nieuwland, Phospholipid composition of in vitro endothelial microparticles and their in vivo thrombogenic properties, Thromb Res, vol.121, issue.6, pp.865-71, 2008.

N. Amabile, A. P. Guerin, A. Leroyer, Z. Mallat, C. Nguyen et al., Circulating Endothelial Microparticles Are Associated with Vascular Dysfunction in Patients with End-Stage Renal Failure, Journal of the American Society of Nephrology, vol.16, issue.11, pp.16-3381, 2005.
DOI : 10.1681/ASN.2005050535

S. P. Ardoin, J. C. Shanahan, and D. S. Pisetsky, The Role of Microparticles in Inflammation and Thrombosis, Scandinavian Journal of Immunology, vol.95, issue.1, pp.159-65, 2007.
DOI : 10.1046/j.1365-2141.2001.03101.x

L. C. Azevedo, M. A. Pedro, and F. R. Laurindo, Circulating Microparticles as Therapeutic Targets in Cardiovascular Diseases, Recent Patents on Cardiovascular Drug Discovery, vol.2, issue.1, pp.41-51, 2007.
DOI : 10.2174/157489007779606121

S. Bernard, R. Loffroy, A. Serusclat, L. Boussel, E. Bonnefoy et al., Increased levels of endothelial microparticles CD144 (VE-Cadherin) positives in type 2 diabetic patients with coronary noncalcified plaques evaluated by multidetector computed tomography (MDCT), Atherosclerosis, vol.203, issue.2, pp.429-464, 2009.
DOI : 10.1016/j.atherosclerosis.2008.07.039

URL : https://hal.archives-ouvertes.fr/hal-00428378

R. Sturk and . Nieuwland, Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner, J Thromb Haemost, vol.1, issue.12, pp.2561-2569, 2003.

C. M. Boulanger, N. Amabile, and A. Tedgui, Circulating Microparticles: A Potential Prognostic Marker for Atherosclerotic Vascular Disease, Hypertension, vol.48, issue.2, pp.180-186, 2006.
DOI : 10.1161/01.HYP.0000231507.00962.b5

O. Soriano, J. P. Zambrano, and Y. S. Ahn, Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism, J Am Coll Cardiol, issue.9, pp.45-1467, 2005.

G. Chironi, A. Simon, B. Hugel, M. D. Pino, J. Gariepy et al., Circulating Leukocyte-Derived Microparticles Predict Subclinical Atherosclerosis Burden in Asymptomatic Subjects, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.26, issue.12, pp.26-2775, 2006.
DOI : 10.1161/01.ATV.0000249639.36915.04

G. N. Chironi, A. Simon, C. M. Boulanger, F. Dignat-george, B. Hugel et al., Circulating microparticles may influence early carotid artery remodeling, Journal of Hypertension, vol.28, issue.4, 2009.
DOI : 10.1097/HJH.0b013e328335d0a8

I. Dursun, H. M. Poyrazoglu, Z. Gunduz, H. Ulger, A. Yykylmaz et al., The relationship between circulating endothelial microparticles and arterial stiffness and atherosclerosis in children with chronic kidney disease, Nephrology Dialysis Transplantation, vol.24, issue.8, pp.24-2511, 2009.
DOI : 10.1093/ndt/gfp066

A. K. Enjeti, L. F. Lincz, and M. Seldon, Detection and Measurement of Microparticles: An Evolving Research Tool for Vascular Biology, Seminars in Thrombosis and Hemostasis, vol.33, issue.8, pp.33-771, 2007.
DOI : 10.1055/s-2007-1000369

J. M. Freyssinet and F. Toti, Formation of procoagulant microparticles and properties, Thrombosis Research, vol.125, pp.46-54
DOI : 10.1016/j.thromres.2010.01.036

J. M. Freyssinet and F. Dignat-george, More on: measuring circulating cell-derived microparticles, Journal of Thrombosis and Haemostasis, vol.3, issue.3, pp.613-617, 2005.
DOI : 10.1016/j.molmed.2004.02.007

B. Goichot, L. Grunebaum, D. Desprez, S. Vinzio, L. Meyer et al., Circulating procoagulant microparticles in obesity, Diabetes & Metabolism, vol.32, issue.1, pp.82-87, 2006.
DOI : 10.1016/S1262-3636(07)70251-3

I. A. Hagberg, Ç. A. Akkøk, T. Lyberg, and J. Kjeldsen-kragh, Apheresis-induced platelet activation:comparison of three types of cell separators, Transfusion, vol.6, issue.1, pp.182-192, 2000.
DOI : 10.1006/bcmd.1995.0025

P. Harrison and C. Gardiner, How to detect and measure microparticles, Hematology Education: European Hematology Association, vol.4, pp.51-56, 2010.

. Witztum, The role of innate immunity in atherogenesis, J Lipid Res, p.50, 2009.

L. L. Horstman, W. Jy, J. J. Jimenez, and Y. S. Ahn, Endothelial microparticles as markers of endothelial dysfunction, Frontiers in Bioscience, vol.9, issue.1-3, pp.1118-1153, 2004.
DOI : 10.2741/1270

B. Hugel, M. C. Martinez, C. Kunzelmann, and J. M. Freyssinet, Membrane Microparticles: Two Sides of the Coin, Physiology, vol.20, issue.1, pp.22-29, 2005.
DOI : 10.1152/physiol.00029.2004

M. Janiszewski, A. O. Do-carmo, M. A. Pedro, E. Silva, E. Knobel et al., Platelet-derived exosomes of septic individuals possess proapoptotic NAD(P)H oxidase activity: A novel vascular redox pathway*, Critical Care Medicine, vol.32, issue.3, pp.818-843, 2004.
DOI : 10.1097/01.CCM.0000114829.17746.19

J. J. Jimenez, W. Jy, L. M. Mauro, L. L. Horstman, C. J. Bidot et al., Endothelial Microparticles (EMP) as Vascular Disease Markers, Adv Clin Chem, vol.39, pp.131-57, 2005.
DOI : 10.1016/S0065-2423(04)39005-0

A. Lawrie, A. Albanyan, R. Cardigan, I. Mackie, and P. Harrison, Microparticle sizing by dynamic light scattering in fresh-frozen plasma, Vox Sanguinis, vol.51, issue.3, pp.206-218, 2009.
DOI : 10.1111/j.1423-0410.2008.01151.x

C. M. Tedgui and . Boulanger, Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques, J Am Coll Cardiol, vol.49, issue.7, pp.772-779, 2007.

P. Brandes, E. Lutgens, A. Tedgui, and C. M. Boulanger, CD40 ligand+ microparticles from human atherosclerotic plaques stimulate endothelial proliferation and angiogenesis a potential mechanism for intraplaque neovascularization, J Am Coll Cardiol, issue.16, pp.52-1302, 2008.

A. S. Leroyer, A. Tedgui, and C. M. Boulanger, Role of microparticles in atherothrombosis, Journal of Internal Medicine, vol.89, issue.5, pp.528-565, 2008.
DOI : 10.1046/j.1365-2141.2003.04716.x

S. F. Lynch and C. A. Ludlam, Plasma microparticles and vascular disorders, British Journal of Haematology, vol.89, issue.1, pp.36-48, 2007.
DOI : 10.1016/S0049-3848(02)00354-7

N. Mackman, The Role of Tissue Factor and Factor VIIa in Hemostasis, Anesthesia & Analgesia, vol.108, issue.5, pp.1447-52, 2009.
DOI : 10.1213/ane.0b013e31819bceb1

Z. Mallat, H. Benamer, B. Hugel, J. Benessiano, P. G. Steg et al., Elevated Levels of Shed Membrane Microparticles With Procoagulant Potential in the Peripheral Circulating Blood of Patients With Acute Coronary Syndromes, Circulation, vol.101, issue.8, pp.841-844, 2000.
DOI : 10.1161/01.CIR.101.8.841

S. F. Mause, P. Von-hundelshausen, A. Zernecke, R. R. Koenen, and C. Weber, Platelet Microparticles: A Transcellular Delivery System for RANTES Promoting Monocyte Recruitment on Endothelium, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.25, issue.7, pp.25-1512, 2005.
DOI : 10.1161/01.ATV.0000170133.43608.37

M. Mayr, D. Grainger, U. Mayr, A. S. Leroyer, G. Leseche et al., Proteomics, Metabolomics, and Immunomics on Microparticles Derived From Human Atherosclerotic Plaques, Proteomics, metabolomics, and immunomics on microparticles derived from human atherosclerotic plaques, pp.379-88, 2009.
DOI : 10.1161/CIRCGENETICS.108.842849

A. E. Michelsen, A. T. Noto, E. Brodin, E. B. Mathiesen, F. Brosstad et al., Elevated levels of platelet microparticles in carotid atherosclerosis and during the postprandial state, Thrombosis Research, vol.123, issue.6, pp.881-887, 2009.
DOI : 10.1016/j.thromres.2008.10.016

J. V. Mitsios, M. P. Vini, D. Stengel, E. Ninio, and A. D. Tselepis, Human Platelets Secrete the Plasma Type of Platelet-Activating Factor Acetylhydrolase Primarily Associated With Microparticles, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.26, issue.8, pp.26-1907, 2006.
DOI : 10.1161/01.ATV.0000228821.79588.ef

O. Morel, B. Hugel, L. Jesel, Z. Mallat, F. Lanza et al., Circulating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb-IIIa antagonists, Journal of Thrombosis and Haemostasis, vol.113, issue.7, pp.1118-1144, 2004.
DOI : 10.1111/j.1538-7836.2004.00805.x

O. Morel, F. Toti, B. Bakouboula, L. Grunebaum, and J. M. Freyssinet, Procoagulant Microparticles: ???Criminal Partners??? in Atherothrombosis and Deleterious Cellular Exchanges, Pathophysiology of Haemostasis and Thrombosis, vol.35, issue.1-2, pp.15-22, 2006.
DOI : 10.1159/000093538

J. M. Chenard, P. Freyssinet, J. P. Bareiss, F. Mazzucotelli, and . Toti, Endothelial cell activation contributes to the release of procoagulant microparticles during acute cardiac allograft rejection, J Heart Lung Transplant, vol.27, issue.1, pp.38-45, 2008.

S. Nomura, A. Shouzu, S. Omoto, M. Nishikawa, S. Fukuhara et al., Losartan and Simvastatin Inhibit Platelet Activation in Hypertensive Patients, Journal of Thrombosis and Thrombolysis, vol.61, issue.Suppl, pp.177-85, 2004.
DOI : 10.1007/s11239-005-0343-8

S. Nomura, N. Inami, A. Shouzu, S. Omoto, Y. Kimura et al., The effects of pitavastatin, eicosapentaenoic acid and combined therapy on platelet-derived microparticles and adiponectin in hyperlipidemic, diabetic patients, Platelets, vol.28, issue.1, pp.16-22, 2009.
DOI : 10.1016/S0021-9150(01)00433-6

B. Osterud and E. Bjorklid, Sources of Tissue Factor, Seminars in Thrombosis and Hemostasis, vol.32, issue.01, pp.11-23, 2006.
DOI : 10.1055/s-2006-933336

J. Paul and B. Baudin, Physiopathologie de l???ath??roscl??rose et marqueurs pr??coces, Revue Francophone des Laboratoires, vol.2009, issue.409, pp.29-50, 2009.
DOI : 10.1016/S1773-035X(09)70199-6

P. Richard, A. , W. Jy, J. J. Jimenez, L. M. Mauro et al., Effects of severe hypertension on endothelial and platelet microparticles, Hypertension, issue.2, pp.41-211, 2003.

S. L. Pfister, Role of Platelet Microparticles in the Production of Thromboxane by Rabbit Pulmonary Artery, Hypertension, vol.43, issue.2, pp.428-461, 2004.
DOI : 10.1161/01.HYP.0000110906.77479.91

A. Piccin, W. G. Murphy, and O. P. Smith, Circulating microparticles: pathophysiology and clinical implications, Blood Reviews, vol.21, issue.3, pp.157-71, 2007.
DOI : 10.1016/j.blre.2006.09.001

A. Rank, R. Nieuwland, S. Liebhardt, M. Iberer, S. Grützner et al., Apheresis platelet concentrates contain platelet-derived and endothelial cell-derived microparticles, Vox Sanguinis, vol.91, issue.2, pp.179-86, 2011.
DOI : 10.1111/j.1423-0410.2010.01385.x

F. Sabatier, V. Roux, F. Anfosso, L. Camoin, J. Sampol et al., Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity, Blood, vol.99, issue.11, pp.99-3962, 2002.
DOI : 10.1182/blood.V99.11.3962

J. Simak, M. P. Gelderman, H. Yu, V. Wright, and A. E. Baird, Circulating endothelial microparticles in acute ischemic stroke: a link to severity, lesion volume and outcome, Journal of Thrombosis and Haemostasis, vol.25, issue.6, pp.1296-302, 2006.
DOI : 10.1074/jbc.M300351200

A. Tesse, M. C. Martinez, B. Hugel, K. Chalupsky, C. D. Muller et al., Upregulation of proinflammatory proteins through NF-kappaB pathway by shed membrane microparticles results in vascular hyporeactivity, Arterioscler Thromb Vasc Biol, issue.12, pp.25-2522, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00129995

A. F. Tramontano, J. O. Leary, A. D. Black, R. Muniyappa, M. V. Cutaia et al., Statin decreases endothelial microparticle release from human coronary artery endothelial cells: implication for the Rho-kinase pathway, Biochemical and Biophysical Research Communications, vol.320, issue.1, pp.34-42, 2004.
DOI : 10.1016/j.bbrc.2004.05.127

M. J. Vanwijk, E. Vanbavel, A. Sturk, and R. Nieuwland, Microparticles in cardiovascular diseases, Cardiovascular Research, vol.59, issue.2, pp.277-87, 2003.
DOI : 10.1016/S0008-6363(03)00367-5

N. Werner, S. Wassmann, P. Ahlers, S. Kosiol, and G. Nickenig, Circulating CD31+/Annexin V+ Apoptotic Microparticles Correlate With Coronary Endothelial Function in Patients With Coronary Artery Disease, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.26, issue.1, pp.112-118, 2006.
DOI : 10.1161/01.ATV.0000191634.13057.15

G. Watts, F. Van-bockxmeer, T. Bates, J. Burnett, A. Juniper et al., A New Model of Care for Familial Hypercholesterolaemia from Western Australia: Closing a Major Gap in Preventive Cardiology, Heart, Lung and Circulation, vol.19, issue.7, pp.419-422, 2010.
DOI : 10.1016/j.hlc.2010.02.002

P. Wolf, . References-bibliographiques-c-reactive, and . Proteine, The Nature and Significance of Platelet Products in Human Plasma, British Journal of Haematology, vol.8, issue.3, pp.269-88, 1967.
DOI : 10.1136/jcp.6.1.34

A. Agrawal, A C-Reactive Protein Mutant That Does Not Bind to Phosphocholine and Pneumococcal C-Polysaccharide, The Journal of Immunology, vol.169, issue.6, pp.3217-3239, 2002.
DOI : 10.4049/jimmunol.169.6.3217

C. M. Albert, Prospective Study of C-Reactive Protein, Homocysteine, and Plasma Lipid Levels as Predictors of Sudden Cardiac Death, Circulation, vol.105, issue.22, pp.105-2595, 2002.
DOI : 10.1161/01.CIR.0000017493.03108.1C

A. A. Ariyo, C. Thach, and R. Tracy, Lp(a) lipoprotein, vascular disease, and mortality in the elderly, N Engl J Med, issue.22, pp.349-2108, 2003.

A. Bayes-genis, Pregnancy-Associated Plasma Protein A as a Marker of Acute Coronary Syndromes, New England Journal of Medicine, vol.345, issue.14, pp.345-1022, 2001.
DOI : 10.1056/NEJMoa003147

L. M. Biasucci, Elevated Levels of C-Reactive Protein at Discharge in Patients With Unstable Angina Predict Recurrent Instability, Circulation, vol.99, issue.7, pp.855-60, 1999.
DOI : 10.1161/01.CIR.99.7.855

L. M. Biasucci, Increasing Levels of Interleukin (IL)-1Ra and IL-6 During the First 2 Days of Hospitalization in Unstable Angina Are Associated With Increased Risk of In-Hospital Coronary Events, Circulation, vol.99, issue.16, pp.99-2079, 1999.
DOI : 10.1161/01.CIR.99.16.2079

G. J. Blake and P. M. Ridker, C-reactive protein and prognosis after percutaneous coronary intervention, European Heart Journal, vol.23, issue.12, pp.923-928, 2002.
DOI : 10.1053/euhj.2001.3130

H. B. Brewer and . Jr, High-Density Lipoproteins: A New Potential Therapeutic Target for the Prevention of Cardiovascular Disease, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.24, issue.3, pp.387-91, 2004.
DOI : 10.1161/01.ATV.0000121505.88326.d2

D. J. Brull, Human CRP Gene Polymorphism Influences CRP Levels: Implications for the Prediction and Pathogenesis of Coronary Heart Disease, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.23, issue.11, pp.23-2063, 2003.
DOI : 10.1161/01.ATV.0000084640.21712.9C

D. Chan, G. Watts, S. Gan, E. Ooi, and P. Barrett, Effect of Ezetimibe on Hepatic Fat, Inflammatory Markers, and Apolipoprotein B-100 Kinetics in Insulin-Resistant Obese Subjects on a Weight Loss Diet, Diabetes Care, vol.33, issue.5, pp.33-1134, 2010.
DOI : 10.2337/dc09-1765

D. Chan, G. Watts, P. Barrett, L. Beilin, and T. Mori, Effect of atorvastatin and fish oil on plasma high-sensitivity C-reactive protein concentrations in individuals with visceral obesity

M. K. Chang, C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids, Proceedings of the National Academy of Sciences, vol.99, issue.20, pp.99-13043, 2002.
DOI : 10.1073/pnas.192399699

P. H. Dessein, B. I. Joffe, and A. E. Stanwix, High sensitivity C-reactive protein as a disease activity marker in rheumatoid arthritis, J Rheumatol, issue.6, pp.31-1095, 2004.

E. E. Diehl, Immunohistochemical Localization of Modified C-Reactive Protein Antigen in Normal Vascular Tissue, The American Journal of the Medical Sciences, vol.319, issue.2, pp.79-83, 2000.
DOI : 10.1016/S0002-9629(15)40692-5

A. M. Gotto, H. J. Jr, R. J. Pownall, and . Havel, [1] Introduction to the plasma lipoproteins, Methods Enzymol, vol.128, pp.3-41, 1986.
DOI : 10.1016/0076-6879(86)28061-1

J. C. Guilland, L???hyperhomocyst??in??mie : facteur de risque cardiovasculaire ou simple marqueur ?, Pathologie Biologie, vol.51, issue.2, pp.111-132, 2003.
DOI : 10.1016/S0369-8114(03)00105-6

D. E. Handy and J. Loscalzo, Homocysteine and atherothrombosis: Diagnosis and treatment, Current Atherosclerosis Reports, vol.288, issue.4
DOI : 10.1007/s11883-003-0050-x

K. Hatanaka, Immunohistochemical localization of C-reactive protein-binding sites in human atherosclerotic aortic lesions by a modified streptavidin-biotin-staining method, Pathology International, vol.367, issue.9, pp.45-635, 1995.
DOI : 10.1111/j.1440-1827.1995.tb03515.x

M. Hundt, M. Zielinska-skowronek, and R. E. Schmidt, Lack of specific receptors for Creactive protein on white blood cells, Eur J Immunol, issue.12, pp.31-3475, 2001.

I. Ikonomidis, Increased Proinflammatory Cytokines in Patients With Chronic Stable Angina and Their Reduction By Aspirin, Circulation, vol.100, issue.8, pp.793-801, 1999.
DOI : 10.1161/01.CIR.100.8.793

Y. Inokubo, Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome, American Heart Journal, vol.141, issue.2, pp.211-218, 2001.
DOI : 10.1067/mhj.2001.112238

A. Jager, Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study, Diabetes, vol.49, issue.3, pp.485-91, 2000.
DOI : 10.2337/diabetes.49.3.485

A. H. Kaftan and O. Kaftan, Coronary Artery Disease and Infection with Chlamydia Pneumonia., Japanese Heart Journal, vol.41, issue.2, pp.165-72, 2000.
DOI : 10.1536/jhj.41.165

H. Kai, Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes, Journal of the American College of Cardiology, vol.32, issue.2, pp.368-72, 1998.
DOI : 10.1016/S0735-1097(98)00250-2

W. Koenig, Predicting risk and treatment benefit in atherosclerosis: the role of C-reactive protein, International Journal of Cardiology, vol.98, issue.2, pp.199-206, 2005.
DOI : 10.1016/j.ijcard.2004.05.019

W. K. Lagrand, C-Reactive Protein as a Cardiovascular Risk Factor : More Than an Epiphenomenon?, Circulation, vol.100, issue.1, pp.96-102, 1999.
DOI : 10.1161/01.CIR.100.1.96

S. H. Li, C-Reactive Protein Upregulates Complement-Inhibitory Factors in Endothelial Cells, Circulation, vol.109, issue.7, pp.833-839, 2004.
DOI : 10.1161/01.CIR.0000117087.27524.0E

G. Liuzzo, The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina, New England Journal of Medicine, vol.331, issue.7, pp.331-417, 1994.
DOI : 10.1056/NEJM199408183310701

Y. Noji, Circulating Matrix Metalloproteinases and Their Inhibitors in Premature Coronary Atherosclerosis, Clinical Chemistry and Laboratory Medicine, vol.39, issue.5, pp.380-384, 2001.
DOI : 10.1515/CCLM.2001.060

C. J. Packard, Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group, N Engl J Med, issue.16, pp.343-1148, 2000.

M. B. Pepys, I. F. Rowe, and M. L. Baltz, C-Reactive Protein, Int Rev Exp Pathol, vol.27, pp.83-111, 1985.
DOI : 10.1006/rwei.1999.0175

P. M. Ridker, Clinical Application of C-Reactive Protein for Cardiovascular Disease Detection and Prevention, Circulation, vol.107, issue.3, pp.363-372, 2003.
DOI : 10.1161/01.CIR.0000053730.47739.3C

P. M. Ridker, Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events, New England Journal of Medicine, vol.347, issue.20, pp.347-1557, 2002.
DOI : 10.1056/NEJMoa021993

P. M. Ridker, C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women, New England Journal of Medicine, vol.342, issue.12, pp.342-836, 2000.
DOI : 10.1056/NEJM200003233421202

P. M. Ridker, C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women, Circulation, vol.107, issue.3, pp.391-398, 2003.
DOI : 10.1161/01.CIR.0000055014.62083.05

P. M. Ridker, Established and Emerging Plasma Biomarkers in the Prediction of First Atherothrombotic Events, Circulation, vol.109, issue.25_suppl_1, pp.6-19, 2004.
DOI : 10.1161/01.CIR.0000133444.17867.56

P. M. Ridker, Plasma Concentration of Interleukin-6 and the Risk of Future Myocardial Infarction Among Apparently Healthy Men, Circulation, vol.101, issue.15, pp.1767-72, 2000.
DOI : 10.1161/01.CIR.101.15.1767

P. M. Ridker, Plasma Homocysteine Concentration, Statin Therapy, and the Risk of First Acute Coronary Events, Circulation, vol.105, issue.15, pp.1776-1785, 2002.
DOI : 10.1161/01.CIR.0000014447.06099.FB

P. M. Ridker, Inflammatory Biomarkers, Statins, and the Risk of Stroke: Cracking a Clinical Conundrum, Circulation, vol.105, issue.22, pp.2583-2588, 2002.
DOI : 10.1161/01.CIR.0000017822.82512.62

P. M. Ridker, J. E. Buring, and N. Rifai, Soluble P-Selectin and the Risk of Future Cardiovascular Events, Circulation, vol.103, issue.4, pp.491-496, 2001.
DOI : 10.1161/01.CIR.103.4.491

P. M. Ridker, M. J. Stampfer, and N. Rifai, Novel Risk Factors for Systemic Atherosclerosis, JAMA, vol.285, issue.19, pp.285-2481, 2001.
DOI : 10.1001/jama.285.19.2481

N. Rifai and P. M. Ridker, High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease, Clin Chem, issue.3, pp.47-403, 2001.

J. Siegel, Interactions of C-reactive protein with the complement system. II. C- reactive protein-mediated consumption of complement by poly-L-lysine polymers and other polycations, Journal of Experimental Medicine, vol.142, issue.3, pp.709-730, 1975.
DOI : 10.1084/jem.142.3.709

A. D. Simon, Circulating levels of IL-1beta, a prothrombotic cytokine, are elevated in unstable angina versus stable angina, J Thromb Thrombolysis, issue.93, pp.217-239, 2000.

A. J. Szalai, Association between baseline levels of C-reactive protein (CRP) and a dinucleotide repeat polymorphism in the intron of the CRP gene, Genes and Immunity, vol.3, issue.1, pp.14-23, 2002.
DOI : 10.1038/sj.gene.6363820

S. Taskinen, Binding of C-reactive protein to modified low-density-lipoprotein particles: identification of cholesterol as a novel ligand for C-reactive protein, Biochemical Journal, vol.367, issue.2, pp.367-403, 2002.
DOI : 10.1042/bj20020492

D. Thompson, M. B. Pepys, and S. P. Wood, The physiological structure of human C-reactive protein and its complex with phosphocholine, Structure, vol.7, issue.2, pp.169-77, 1999.
DOI : 10.1016/S0969-2126(99)80023-9

J. Torzewski, C-Reactive Protein Frequently Colocalizes With the Terminal Complement Complex in the Intima of Early Atherosclerotic Lesions of Human Coronary Arteries, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.18, issue.9, pp.1386-92, 1998.
DOI : 10.1161/01.ATV.18.9.1386

T. J. Van-berkel, LDL receptor-independent and -dependent uptake of lipoproteins, Atherosclerosis, vol.118, pp.43-50, 1995.
DOI : 10.1016/0021-9150(95)90072-1

S. Verma, P. E. Szmitko, and E. T. Yeh, C-Reactive Protein: Structure Affects Function, Circulation, vol.109, issue.16, pp.1914-1921, 2004.
DOI : 10.1161/01.CIR.0000127085.32999.64

J. E. Volanakis, Human C-reactive protein: expression, structure, and function, Molecular Immunology, vol.38, issue.2-3, pp.189-97, 2001.
DOI : 10.1016/S0161-5890(01)00042-6

A. T. Wong, Effect of laparoscopic sleeve gastrectomy on elevated C-reactive protein and atherogenic dyslipidemia in morbidly obese patients, Clinical Biochemistry, vol.44, issue.4, pp.342-344, 2011.
DOI : 10.1016/j.clinbiochem.2010.12.004

P. Woo, J. R. Korenberg, and A. S. Whitehead, Characterization of genomic and complementary DNA sequence of human C-reactive protein, and comparison with the complementary DNA sequence of serum amyloid P component, J Biol Chem, issue.24, pp.260-13384, 1985.

K. Yasojima, Generation of C-Reactive Protein and Complement Components in Atherosclerotic Plaques, The American Journal of Pathology, vol.158, issue.3, pp.1039-51, 2001.
DOI : 10.1016/S0002-9440(10)64051-5

R. Y. Zee and P. M. Ridker, Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis, Atherosclerosis, vol.162, issue.1, pp.217-226, 2002.
DOI : 10.1016/S0021-9150(01)00703-1

B. Zethelius, Use of Multiple Biomarkers to Improve the Prediction of Death from Cardiovascular Causes, New England Journal of Medicine, vol.358, issue.20, pp.358-2107, 2008.
DOI : 10.1056/NEJMoa0707064

Y. X. Zhang, Coronary C-reactive protein distribution: its relation to development of atherosclerosis, Atherosclerosis, vol.145, issue.2, pp.375-384, 1999.
DOI : 10.1016/S0021-9150(99)00105-7